Orchestra BioMed Holdings, Inc. (OBIO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Orchestra BioMed Holdings, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3023.28x | -2.41x | -6.18x | -7.56x | -8.96x | -12.27x |
| P/B Ratio | 2513.96x | 4.47x | 4.46x | 4.84x | -2.89x | -5.40x |
| P/S Ratio | 4758.67x | 55.83x | 109.91x | 71.95x | -263.60x | 45.93x |
| Profitability | ||||||
| Gross Margin | 98.9% | 92.3% | 93.3% | 90.9% | 125.4% | 97.5% |
| Operating Margin | -154.7% | -2437.5% | -1866.2% | -924.3% | 2787.6% | -328.8% |
| Net Margin | -157.4% | -2313.3% | -1779.7% | -951.3% | 2943.0% | -374.5% |
| EBITDA Margin | -153.8% | -2425.8% | -1855.8% | -918.1% | 2764.5% | -326.4% |
| Liquidity | ||||||
| Current Ratio | 6.45x | 4.27x | 7.95x | 4.56x | 0.92x | 2.52x |
| Quick Ratio | 6.43x | 4.26x | 7.94x | 4.55x | 0.92x | 2.52x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.50x | 0.02x | 0.23x | -0.08x | -0.19x |
YoY = year-over-year change. Source: FMP..